1. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Gershenwald;CA: a Cancer J Clin,2017
2. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma;Weber;N Engl J Med,2017
3. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma;Eggermont;N Engl J Med,2018
4. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma;Long;N Engl J Med,2017
5. Systemic therapy for Melanoma: ASCO guideline update;Seth;J Clin Oncol,2023